You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • AB0683 Trough infliximab levels and anti-infliximab antibodies in spondyloarthritis patients on treatment with low dose infliximab: a single centre cross-sectional study

Article metrics

Article menu

Download PDFPDF

Abstracts Accepted for Publication
Spondyloarthritis - treatment
AB0683 Trough infliximab levels and anti-infliximab antibodies in spondyloarthritis patients on treatment with low dose infliximab: a single centre cross-sectional study
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 2017703
Jul 20173406
Aug 20172207
Sep 20172204
Oct 20171804
Nov 20171000
Dec 20171600
Jan 20182808
Feb 20181000
Mar 2018801
Apr 20181000
May 20185002
Jun 20181000
Jul 20181800
Aug 20181407
Sep 2018401
Oct 2018601
Nov 2018204
Dec 2018603
Jan 2019203
Mar 2019002
Apr 2019202
May 2019606
Jun 2019202
Jul 2019603
Aug 2019704
Sep 2019001
Oct 2019201
Nov 2019003
Dec 2019200
Feb 2020201
Mar 2020202
Apr 2020001
May 2020202
Jun 2020400
Jul 2020802
Aug 202012022
Sep 20201003
Oct 2020200
Nov 2020501
Dec 2020400
Feb 2021002
Apr 2021201
May 2021002
Jun 2021001
Jul 2021003
Aug 2021002
Sep 2021004
Oct 202114016
Nov 2021208
Dec 2021402
Jan 20221000
Feb 2022800
Mar 2022002
Apr 2022200
May 2022808
Jun 20223402
Jul 20221301
Aug 20221404
Sep 2022203
Oct 2022804
Nov 2022200
Dec 2022601
Jan 2023702
Feb 2023400
Mar 20231001
May 2023002
Jun 2023200
Jul 2023404
Aug 2023200
Sep 2023201
Oct 2023001
Nov 2023001
Dec 20231802
Jan 20241004
Feb 2024403
Mar 2024603
Total5730202